Ag-telmisartan Tablet: Overweight & Underweight Tablets

Recall Summary AG-Telmisartan tablets (40 mg and 80 mg) are being recalled across Canada because some tablets weigh more or less than they should, indicating a product quality issue. This recall affects all consumers who have this medication. The recall is classified as Class I, meaning there is a serious potential health risk.

Product
AG-Telmisartan 40 mg & 80 tablet
Reason
Product quality
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2024-09-09
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/56a7b984-b4fb-46d9-ae4f-0343c4034a98